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ARTICLE
Mechanisms for cellular uptake of nanosized clinical MRI contrast agents
Emily J. Guggenheima , Joshua Z. Rappoportb,c and Iseult Lyncha
aSchool of Geography, Earth and Environmental Sciences, University of Birmingham, Birmingham, UK; bCenter for Advanced
Microscopy, and Nikon Imaging Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; cCore Technologies
for Life Sciences, Boston College, MA, USA
ABSTRACT
Engineered Nanomaterials (NMs), such as Superparamagnetic Iron Oxide Nanoparticles (SPIONs),
offer significant benefits in a wide range of applications, including cancer diagnostic and thera-
peutic strategies. However, the use of NMs in biomedicine raises safety concerns due to lack of
knowledge on possible biological interactions and effects. The initial basis for using SPIONs as
biomedical MRI contrast enhancement agents was the idea that they are selectively taken up by
macrophage cells, and not by the surrounding cancer cells. To investigate this claim, we ana-
lyzed the uptake of SPIONs into well-established cancer cell models and benchmarked this
against a common macrophage cell model. In combination with fluorescent labeling of compart-
ments and siRNA silencing of various proteins involved in common endocytic pathways, the
mechanisms of internalization of SPIONs in these cell types has been ascertained utilizing
reflectance confocal microscopy. Caveolar mediated endocytosis and macropinocytosis are both
implicated in SPION uptake into cancer cells, whereas in macrophage cells, a clathrin-dependant
route appears to predominate. Colocalization studies confirmed the eventual fate of SPIONs as
accumulation in the degradative lysosomes. Dissolution of the SPIONs within the lysosomal
environment has also been determined, allowing a fuller understanding of the cellular interac-
tions, uptake, trafficking and effects of SPIONs within a variety of cancer cells and macrophages.
Overall, the behavior of SPIONS in non-phagocytotic cell lines is broadly similar to that in the
specialist macrophage cells, although some differences in the uptake patterns are apparent.
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Introduction
A nanoparticle (NP) is commonly defined as a
material with at least one dimension on the nano-
scale (1–100 nm), and the term encompasses a
broad range of particles including natural, incidental
and manufactured or engineered nanoparticles and
their applications (Hansen et al. 2008; Loehr et al.
2016; Moore 2006; Handy, Owen and Valsami-Jones
2008; Park et al. 2008). NPs often have very differ-
ent properties to their bulk counterpart including
surface area and optical/electrical properties,
providing opportunities spanning a range of disci-
plines. Diagnostics and therapeutics are key applica-
tion areas for nanotechnology; around 80% of NPs
in clinical phases of development focus on anti-can-
cer strategies (Sch€utz et al. 2013). NPs can incorpor-
ate drugs, imaging agents and even genetic
material, that can be passively or actively targeted
to specific locations within the body, to increase
specificity and reduce unwanted off-target toxicity
(Iyer et al. 2006; Byrne, Betancourt and Brannon-
Peppas 2008; Bahrami et al. 2017). Many applica-
tions utilize the inherent optical characteristics of
NPs in biomedical imaging, such as the use of gold
NPs for computerized tomography imaging contrast
enhancement and quantum dots for cancer cell
labeling (Gao et al. 2004; Re, Moresco, and
Masserini 2012; Zhang, Ross, and Roeder 2010).
Small (<30 nm in diameter) magnetic NPs, such
as iron oxide, have received considerable interest
for use in biomedical applications due to their
superparamagnetism (Bean and Livingston 1959;
Mahmoudi et al. 2011; Fuchigami et al. 2012;
Neuwelt et al. 2015). These superparamagnetic iron
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oxide nanoparticles (SPIONs) exhibit high magnetic
susceptibility, such that upon application of an
external magnetic field, magnetization can be
induced (Mahmoudi et al. 2011; Kolhatkar et al.
2013). Following removal of the magnetic field the
particles no longer show magnetization, which is
important for biomedical applications as it prevents
NP agglomeration and subsequent embolization of
vessels. These properties, combined with the
assumed biocompatibility, small size and modifiable
surface area, render SPIONs particularly attractive
candidates for use as Magnetic Resonance Imaging
(MRI) contrast enhancement agents, for hyperther-
mia tumor therapy and as directed drug delivery
systems (Hofmann-amtenbrink et al. 2009; Kievit
and Zhang 2011; Wang and Cuschieri 2013;
Neuwelt et al. 2015). The apparent selective uptake
of SPIONs into macrophage cells, in particular, liver
Kupffer cells, led to the initial use of SPION-
enhanced MRI for hepatic lesion imaging (Stark
et al. 1988; Reimer and Tombach 1998; Reimer et al.
2000; Bulte and Kraitchman 2004). Ultrasmall
(<10 nm) SPIONs (uSPIONs), that are cleared though
the lymphatic system, have since been used for
contrast enhancement in lymph node imaging to
aid the clinical staging of cancer metastasis (Wang
2015; Fortuin et al. 2017; Harisinghani et al. 2003;
Choi et al. 2007). Other types of SPIONs include
those larger than 300 nm (such as GastroMark), for
bowel MRI contrast, and below 20 nm for bone mar-
row and perfusion imaging (Wang 2011). The mag-
netic properties of SPIONs also allow them to be
specifically targeted to a pathological site using an
applied external magnetic field, facilitating accumu-
lation of a conjugated drug without the need for
targeting ligands; the applied field can then be
altered to modulate drug release, or drug release
can be initiated enzymatically by changes in physio-
logical conditions such as pH (Freeman, Arrott and
Watson 1960; Goodwin et al. 1999; Kumar et al.
2010; Wahajuddin and Arora 2012; Wang 2015).
However, a number of concerns remain with using
magnetic fields to target deep into the body,
including the active depth and field strength of
magnets and the potential for localized iron over-
load (Singh et al. 2010; Wahajuddin and Arora 2012;
Shen et al. 2015).
Various formulations of SPIONs have been intro-
duced over the past few years for clinical
applications, including ferumoxide (Feridex – USA,
Endorem – Europe; Hydrodynamic Size (HDS) 120 –
180 nm), Ferucarbotran (Resovist – HDS 60 nm) and
Combidex/Sinerem (30 nm) (European Medicines
Agency 2008; Wang 2011). However, lack of clear
benefits, efficacy, specificity and clinical data led to
the withdrawal of the majority of SPIONs – Resovist
in 2009; Ferumoxide and Combidex in 2008.
Combidex has since been reintroduced in the
Netherlands, indicating a good safety profile and
therefore holds potential for continued use within
lymphography (Fortuin et al. 2017). Inadequate
understanding of NP-cell interactions and the post-
internalization fate of the NPs are key data gaps for
clinical SPIONs. There are numerous potential fac-
tors that determine the biological uptake, effects
and fate of NPs that can be dependent upon the
intrinsic NP properties themselves, the properties of
the medium they are exposed to and the internal-
ization properties of the cell populations being tar-
geted or exposed (Lynch et al. 2013, 2014).
Therefore, it is vital that the properties of NPs are
extensively studied and characterized, in order to
understand the subsequent biological effects and
make accurate conclusions regarding dose-response
within nanosafety investigations.
The conventional usage of SPIONs for MRI con-
trast assumes exclusion from the cells and tissues
of interest, for example from solid tumors. Many of
the traditional uses of SPIONs rely on their uptake
by macrophage cells only. However, the ubiquity of
NP uptake, even by non-phagocytotic cells, is now
well established and thus we postulated that cancer
cells also internalize SPIONs, thus potentially reduc-
ing their efficacy as contrast agents. NPs are effi-
ciently internalized by a variety of cell types
through a combination of uptake routes, including
but not limited to, clathrin mediated endocytosis
(CME), caveolar endocytosis, macropinocytosis and,
in specialized cells, phagocytosis (Ivanov 2008;
Sahay, Alakhova and Kabanov 2010; Gu et al. 2011;
Zhao et al. 2011; Kafshgari, Harding and Voelcker
2015). Endocytosis pathways are often characterized
by their sensitivity to different pharmacological
inhibitors, a tool that can be manipulated with
some success to determine the route of NP uptake
into cells using tools such as microscopy (dos
Santos et al. 2011a, 2011b; Kuhn et al. 2014).
However, these inhibitors are often nonspecific and
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lead to unwanted side-effects (Ivanov 2008), and
fail to completely shut-off NP uptake. Alternatively,
NP uptake mechanisms can be deduced through
red/green image overlays of NP signal with signal
from cargo specific to certain pathways. However
these types of overlays are subjective, and can only
be truly representative when the channel histo-
grams are roughly equal, a scenario that is unlikely
when different fluorophores are used (Bolte and
Cordelieres 2006; Soenen et al. 2010a, 2010b; Pike
et al. 2017). Additionally, while colocalization stud-
ies can be indicative of NP and labeled cargo resid-
ing within a common membrane bound organelle,
this does not necessarily imply a common mechan-
ism of internalization. Determining the method of
internalization solely by signal colocalization with a
labeled pathway cargo is particularly confounding
as different endocytotic routes can converge into a
common early sorting compartment (Mayor, Presley
and Maxfield 1993; Jovic et al. 2010). An alternative,
more specific approach for investigating uptake
mechanisms utilizes siRNA silencing of proteins that
are instrumental to the functioning of specific
internalization pathways.
Following uptake via receptor-mediated endo-
cytosis, cargo, such as NPs, are encapsulated within
vesicles that traffic through the endosomal trans-
port network (Bucci et al. 1992; Ullrich et al. 1996;
Vanlandingham and Ceresa 2009; Sandin et al.
2012). The highly conserved Rab GTPases are
involved in the regulation of endosomal trafficking,
and can therefore be used to identify specific com-
partments (Elkin, Lakoduk, and Schmid 2016). Rab5/
5A regulates the kinetics of membrane trafficking
through early endosomes, and plays a role in
Rab7A recruitment (Bucci et al. 1992; Feng, Press,
and Wandinger-Ness 1995; Elkin, Lakoduk, and
Schmid 2016). Rab7 is involved in the process of
maturation into the late endosomal compartment
and the lysosome, and the ultimate fate of the
cargo is often degradation in this acidic lysosomal
compartment (Bucci et al. 1992, 2000; Ullrich et al.
1996; Vanlandingham and Ceresa 2009).
Degradation of NPs can lead to the release of ions
and, therefore, cellular toxicity. In the case of
SPIONs, this could lead to the release of Fe3þ or
Fe2þ ions within the cell, increase of which are
associated with problems such as iron overload, dis-
turbed iron homeostasis and symptoms of iron
toxicity (Arbab et al. 2005; Levy et al. 2011). This is
particularly relevant in the case of targeting NPs,
where the local concentration is expected to be
exceptionally high, particularly in tissues that lack
replicative potential. For example, it has been indi-
cated recently that uSPION injection in rodent mod-
els leads to thrombosis, oxidative stress (reactive
oxygen species, ROS) and DNA damage in the heart
(Nemmar et al. 2016). However, it has also been
suggested that, with successful specific targeting,
the production of ROS at a desired target (i.e. can-
cer cells – which are more sensitive to ROS) can be
therapeutically advantageous, enhancing cancer cell
death (Kwon et al. 2016). NPs may also escape a
degradative fate if they are recycled back to the
plasma membrane in Rab11 positive compartments
or if they are released from the endo-lysosomal sys-
tem into the cytoplasm (Ullrich et al. 1996).
There is obviously a complex interplay of factors
that determine the uptake, trafficking, and toxicity
of different NP preparations. More investigation is
required to thoroughly understand the cellular
interactions that occur during and following NP
uptake in order to facilitate their safe and effica-
cious use in biomedical applications. Microscopy
remains one of the most utilized techniques to
study NPs, particularly for in vitro investigation. This
is due to the resolution achievable and the ability
to directly visualize signals in context with other
cellular components when coupled with labelling or
staining (B€ose et al. 2014; Guggenheim et al. 2016;
Karreman et al. 2016). Traditionally, Transmission
Electron Microscopy (TEM) or confocal fluorescence
imaging are used, however TEM is time consuming,
laborious and low throughput, while the use of
fluorescent tags has numerous limitations, including
low sensitivity, difficult bio-conjugation, low quan-
tum efficiency and photo-bleaching effects, in add-
ition to potential alteration of NP surface chemistry
if the label is surface-attached, a factor known to
influence biological activity (Sugden 2004; Sigmund
et al. 2008; Patskovsky et al. 2014; Bartczak et al.
2015; Quinn et al. 2015). An alternative for imaging
of NPs is Reflectance Microscopy (RM), where NPs
act as light reflective probes, akin to fluorescent
labeling, enhancing the scattering of light and
introducing strong contrast at their location within
samples (Rastar et al. 2013; Guggenheim et al.
2017). The use of reflectance imaging therefore
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obviates the need for NP fluorescent labeling, and
provides an alternative platform for visualizing NPs
(Sokolov et al. 2004).
This work investigates the cellular interactions of
clinically relevant SPIONs (Siennaþ), which are used
in sentinel lymph node biopsy in breast cancers
(Karakatsanis et al. 2016). During clinical use, the
injection volume of Siennaþ is 2mL, containing
28mg/mL of iron oxide NPs, totaling 56mg injec-
tion dose of SPIONs. Here, Siennaþ uptake into dif-
ferent types of cells (cancer (A549 (alveolar lung),
MDA MB 231 (breast cancer), HeLa (cervial) and
THP-1 derived macrophages) was assessed following
exposure to concentrations in the range of 60-
280 mg/mL, using reflectance-based microscopy
methods in conjunction with cellular fluorescent
labeling and correlative microscopy. This was com-
bined with automated analysis methods, allowing
the assessment of uptake with higher throughput
as compared to the conventional gold standard
TEM imaging. Systematic inhibition of different
pathways within the cells using siRNAs was utilized
to determine which pathways are critical to SPION
uptake in each cell line. The subsequent subcellular
trafficking was then assessed, determining the lyso-
somal fate of the SPIONs. Simulation of the lyso-
somal environment in established fluid mixtures
indicated the fate of the SPIONs within the lyso-
some. Correlative microscopy and automated ana-
lysis methods were applied to determine the
subcellular nature of reflectant objects and confirm
the findings of light microscopy. This combined
approach allows for important conclusions regard-
ing the fate of Siennaþ SPIONs in a range of cells
for enhanced understanding of conditions for their
safe use.
Methods
Nanoparticle suspensions
Siennaþ SPIONs (Endomagnetics, Sysmex UK) were
used throughout. Nominal size of the NPs was
60 nm (4 nm core plus coating). NP stock solutions
were sonicated (XUB18; Grant Instruments,
Shepreth, UK) for 15minutes prior to use and dis-
persed in Serum Containing Media (SCM)
(Dulbecco’s Modified Eagle’s Medium (DMEM) or
Roswell Park Memorial Institute (RPMI) 1640
medium, with 10% Fetal Bovine Serum (FBS), 1%
Penicillin (P) and Streptomycin (S)), or Phosphate
Buffered Saline (PBS), at the specified concentra-
tions for subsequent experiments.
Nanoparticle characterization: dynamic light
scattering (DLS)
Siennaþ SPION hydrodynamic diameter measure-
ments were performed using a Zetasizer Nano ZS
ZEN 3600 (Malvern Instruments Ltd, Malvern, UK).
SPION stock solutions of 28mg/mL were prepared
and diluted in SCM or PBS to the required concen-
trations (280mg/mL, 112 mg/mL, 56 mg/mL).
Solutions were vortexed, and 800 mL of the solution
was pipetted into a disposable DLS glass cuvette.
Diameter was measured using a Standard Operating
Procedure (SOP) for iron oxide: Refractive Index (RI)
2.42, absorption 0.5, 37 C and water as dispersant.
Measurements were taken a minimum of three
times. Surface charge measurements were also
acquired using the Zetasizer Nano ZS ZEN 3600
(Malvern Instruments Ltd, Malvern, U.K.). SPION sol-
utions were prepared as above. The prepared solu-
tion (1mL) was injected into a disposable folded
capillary cell and the zeta potential was measured
using an SOP for iron oxide; RI 2.42; absorption 0.5;
37 C with water as the dispersant. Measurements
were taken a minimum of 3 times.
Nanoparticle characterization: dissolution studies
Dissolution studies were performed at 96 or
144 hours in dH2O or artifical lysosoma; fluid (ALF).
The full composition of ALF is published
(Stebounova, Guio, and Grassian 2011). At time 0,
solutions (200mL) of SPIONS (7,000 ppb) were ali-
quoted into glass bottles and incubated at 37 C. At
each time point, the size by DLS and Zeta potential
were measured as previously described and the pH
of the solution noted. Samples were also prepared
at each time point (from 24 hrs) during the dissol-
ution studies for subsequent elemental analysis
with ICP-OES to detect the level of Fe ions present
within the sample supernatant. At each time point
10mL of solution was transferred into a 3kda
Millipore centrifuge tube (Satorious, UK) and sub-
jected to centrifugal ultrafiltration at 5,000 g for
50minutes. Upernatant samples were then acidified
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by addition of HNO3 to a concentration of 0.2% and
stored at 4 C for analysis. Prior to analysis, a cali-
bration curve was constructed from iron standard
solutions prepared by serial dilution of 1,000 ppm in
2% nitric acid and measured by ICP-OES. Analysis
was performed on a Perkin Elmer ICP-OES Optima
8000 platform. A delay time of 60 seconds was
implemented before each sample infusion and sam-
ples were analyzed in triplicate; read outs were
given as the mean of three triplicates. Calibration
standards were analyzed initially, followed by a
blank. A flow rate of 1mL/min was implemented
with flush time of 10 seconds. A 30 s wash of 2%
HNO3 was applied between each sample to elimin-
ate any carry over.
Cell culture and maintenance
All cell culture techniques were performed under a
sterile tissue culture hood (Gelaire BSB 4a laminar
flow hood; Gelaire Pty Ltd, Australia or SterilGard,
The Baker Company, Sanford, Maine). All solutions
and equipment were bought sterile or sterilized by
autoclave when required. A549 alveolar cells, HeLa
carcinoma cells and MDA-MB231 breast cancer cells
(all from Public Health England Culture Collections
(PHECC), London UK) and THP-1 leukemia cells
(Health Protection Agency Culture Collections
(HPACC), UK) were cultured at 37 C in 5% (v/v) CO2
atmosphere in T75 culture flasks (Invitrogen, UK)
containing DMEM (Lonza) or RPMI 1640 media
(Lonza) supplemented with 10% FBS (v/v) (BioSera
Ltd., Boussens, France) (FBS) and 1% P/S (100 mg/
mL, Invitrogen, UK). Adherent cells were grown to
confluence and passaged using a standard trypsin-
EDTA (0.25%:0.2%) protocol (Invitrogen, UK).
Suspension cells were maintained at 2x105 cells/mL
and passaged by medium splitting.
THP1 differentiation
THP-1 cells (4 x 104) were plated per well of a 24-
well glass-bottom MatTek plate (MatTek Corp,
Maryland, USA) or in 24 well plastic dishes contain-
ing 13mm coverslips in complete RPMI containing
200 nM phorbol 12-myristate 13-acetate (PMA)
(Sigma-Aldrich, UK) for 72 hours. Following PMA
treatment, differentiation of THP-1 cells was
enhanced by replacement of PMA containing
medium with normal SCM without PMA and incu-
bation for a further 48 hours in this PMA rest (PMAr)
phase (Daigneault et al. 2010).
General NP uptake
HeLa, A549, MDA or THP-1 cells were cultured in
appropriate dishes (35mm MatTek dishes; 24-well
MatTek cell culture imaging plates; gridded MatTek
for correlative studies) and incubated overnight.
Cells were treated with Siennaþ SPIONS prepared as
previously described to final concentrations of
280 mg/mL, 112 mg/mL or 56mg/mL in SCM for
either 1 hour, 15 mins or 5minutes (detailed in the
relevant experiments). Following incubation, cells
were washed with PBS (x3) and then treated with
CellTracker Orange (CTO) diluted 1:1000 using the
standard protocol (Invitrogen, UK) for 30minutes.
Cells were then washed twice with PBS followed by
SCM incubation for 30min. Cells were washed twice
with PBS and then fixed using 4% PFA unless other-
wise stated. Prior to imaging, PBS was replaced
with Vectashield (VS) mounting medium containing
4’,6-Diamidino-2-Phenylindole, Dihydrochloride
(DAPI) (Vector Laboratories Ltd, Peterborough,
United Kingdom). Coverslips were removed from
wells using tweezers and mounted cell side down
with VS containing DAPI, with excess mountant
removed by blotting with tissue. Coverslips were
held in place with nail varnish. Slides were stored at
4 C in a refrigerator prior to imaging.
DNA and siRNA constructs
The Rab5-mRFP construct was a gift from Ari
Helenius (Institute of Biochemistry, ETH, Zurich). The
Rab11-mRFP construct was a gift from Prof. Thomas
Kirchausen (Harvard Medical School, Boston, USA).
A non-silencing control (NSC) siRNA (ON-
TARGETplus NON-targeting siRNA; Dharmacon)
designed for use with rat, mouse or human cell
lines was employed as a negative control. The
a-adaptin (AP2 inhibition) siRNA was custom made
with target sequence: 50-AAGAGCAUGUGCACGCUG
GCCA-30 as used in previous studies (Rappoport and
Simon 2009). The caveolin-1 siRNA was a
SMARTpool of 4 siRNAs (ON-TARGETplus Human
Cav1 siRNA; Dharmacon) targeted to caveolin-1. The
P21-protein activated kinase (PAK-1) siRNA was
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custom made with target sequence: 50-
UGAAUGUCUAGGCCGUUAU-30.
Transfection: cDNA transfection
Cells (1x105) were plated in each well of a glass-
bottom 24-well MatTek plate (MatTek), or 24 well
plastic bottom dishes containing 13mm coverslips,
24 hours prior to transfection to give approxi-
mately 70-80% confluence. Cells were then either
transfected with cDNA for Rab5a, Rab7 or Rab11a
or left untransfected for treatment with Lysotracker
DND-99 (Invitrogen, UK). To perform the transfec-
tion: per well, one tube containing 0.5mg cDNA
with 50 mL of Opti-MEM medium (Thermofisher,
UK) solution and a second tube containing 1.5mL
lipofectamine 2000 (LF2000; Invitrogen) with 50 mL
Opti-MEM medium were prepared. Following
5minute Room Temperature (RT) incubation, the
tubes were combined and incubated for a further
15minutes at RT. The mixture was then added
drop-wise to the cells. Cells were incubated for
3 hours before the medium was replaced with
fresh SCM. A second round of transfection was car-
ried out 24 hours post initial transfection to
increase transfection efficiency. Following 48 hr
transfection, cells were treated with SPIONs diluted
in SCM, prepared as previously described, for one
hour. For the lysosomal colocalization studies,
15minutes before the end of the incubation cells
were treated with Lysotracker to stain acidic lyso-
somal compartments. Following treatment, cells
were washed with PBS (X3) and fixed in 4% PFA
as described above.
Transfection: SiRNA transfection
Cells (2 x 105) were plated per well of a 6-well
plate 24 hours prior to transfection. Culture media
was replaced with Opti-MEM media just prior to
transfection treatment. Per well, one tube contain-
ing 7.5 mL Lipofectamine RNAiMAX with 150 mL
OptiMEM medium and a second tube containing
3.75 mL (or 25 pmol) of siRNA with 150 mL Opti-
MEM medium was prepared. Following 5minutes
incubation at RT, the tubes were combined and
incubated for a further 15minutes at RT. The mix-
ture was then added drop-wise to the cells.
Medium was replaced with fresh SCM 24 hours
post transfection to maximize efficiency and cell
viability. A second round of transfection is often
necessary to increase transfection efficiency of sta-
ble proteins such as AP2 (Motley et al. 2003).
Therefore 24 hours post transfection cells were
detached and re-plated into 24 well plates using a
standard trypsin EDTA protocol. A second round of
transfection was then carried out 48 hours post ini-
tial transfection. Following the 72 hrs siRNA trans-
fection treatment performed as described, cells
were treated for 1 hour with 280mg/mL SPIONs
prepared as previously described, followed by a
further 30min incubation with CTO. Cells were
then washed with PBS (X3) and fixed in 4% PFA,
and stored at 4 C for imaging.
Western blotting was used to quantify relative
protein levels following knockdown via siRNA
transfection. Following the specific treatment, cells
were lysed in 1% Triton X-100 (Sigma, UK) in PBS
containing protease inhibitor cocktail (Roche, UK).
Lamelli buffer (3X) was added in a 2:1 ratio to the
lysate. Western blots were performed using the
Mini-Protean Tetra Electrophoresis System (BioRad)
with the standard protocol. All acrylamide gel
details, running, transfer and Tris-Buffered Saline
with Tween (TBST) buffer recipes were prepared as
standard. Briefly, proteins were separated by
Sodium Dodecyl Sulfate (SDS) Polyacrylamide Gel
Electrophoresis (PAGE) on a 12.5% acrylamide
resolving gel with a 4% acrylamide stacking gel at
100mV. Gels were transferred onto nitrocellulose
membranes. The membrane was blocked in 5%
milk solution for 1 hr at RT and subsequently
probed with the relevant primary antibody in 5%
milk overnight at 4 C. The next day the mem-
branes were washed (4 x TBST) and probed with
the relevant secondary antibody for 2 hours at RT.
Primary antibodies used were polyclonal rabbit
anti-AP2 (Santa Cruz Biotechnology), polyclonal
rabbit anti-Cav1 (Abcam), polyclonal rabbit anti-
Pak1 (Abcam) and monoclonal mouse anti-Tubulin
(Tub) (Sigma). Secondary antibodies used were
goat anti-rabbit IRDye 800 and goat anti-mouse
IRDye 680 (Li-Cor Biosciences) for use with an
Odyssey Infrared Detection System (Li-Cor
Biosciences). Quantification of knockdowns was
done relative to Tub and Non-Silencing Control
(NSC) using ImageJ/FIJI software.
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Protein corona isolation
Western blotting was used to identify proteins pre-
sent in the protein corona following isolation from
SCM using stepwise centrifugation steps (Monopoli
et al. 2013). Following protein separation with
PAGE, coomassie and silver staining were employed
for identification of protein corona constituents.
Gels were first washed with dH20. Gels were then
stained with coomassie brilliant blue R-250 (Thermo
Fisher Scientific) at RT for one hour as per the man-
ufacturer’s protocol. Gels were de-stained overnight
at RT to visualize bands, again as per manufac-
turer’s standard protocol. Following coomassie
staining, silver staining was performed using
Proteosilver Staining Kit (Sigma-Aldrich, UK) as per
the manufacturer’s protocol to identify proteins of
low concentration (sensitivity 0.1 ng/mm2). Briefly,
gels were washed with ethanol, sensitized with sil-
ver stain sensitizer, washed with dH2O, then devel-
oped with developer solution. The reaction is
stopped when bands become visible. Bands were
then excised from the gels for LC-MS/MS analysis.
Proteins were reduced for 15min at 60 C using
10 nM DTT and then alkylated at room temperature
for 45minutes with 50mM iodoacetamide. Proteins
were subsequently digested for 16 h at 37 C using
trypsin. Peptides were enriched using ZIPTIPs to
remove any remaining surfactants and other con-
taminants. Samples were injected onto an Ultimate
3000 HPLC (Dionex, Sunnyvale, CA, USA) for sample
concentration and separation. Peptides were con-
centrated on a Thermo C18 PepMAp 100 trapping
column (3 mM, 75 mm x 2 cm) and separated on a
Thermo Nano Series C18 PepMax Nano Series col-
umn (3mM, 75 mm x 15 cm, 100Å) (Thermofisher
Scientific, UK). The solvent system was 0.1% formic
acid in water (mobile phase A) and 0.1% formic
acid in acetonitrile (solvent B), with a linear gradient
of 3.2% A to 44% B in 30minutes at 350 nL/min.
Peptides were eluted directly via a Triversa
Nanomate nanospray source (Advion Biosciences,
NY) into an LTQ Orbitrap Elite mass spectrometer
(ThermoFisher Scientific, Germany). In full scan
mode spectra were collected over a m/z range of
380–1800 at a resolution of 120,000 (at 400m/z),
data dependant analysis precursor selection was
implemented to take the top 7 most intense ions in
each survey scan for collision induced dissociation
MS/MS analysis at a normalized collision energy of
35%. The MS and MS/MS scans were searched
against the Uniprot database using Proteome
Discoverer 1.4 for human and bovine (ThermoFisher
Scientific) with SequestHT algorithm using carbami-
domethylation for fixed modifications and variable
modifications for acetylation (N terminus), acetyl-
ation (K), oxidation (M) and phosphorylation (STY).
The precursor mass tolerance was 10 ppm and the
MS/MS mass tolerance was 0.8 Da. Two missed clea-
vages were allowed and the data were filtered with
a strict false discovery rate (FDR) of 0.01 and a
relaxed FDR of 0.05. The protein grouping filter was
applied and a minimum of two high confident pep-
tides (strict FDR 0.01) were accepted as a real hit.
TEM processing and microscopy
SPIONs (8 mL) were dropped onto 200 mesh
Formvar film copper grids (Agar Scientific, UK).
Following blotting, grids were left to dry for
24 hours prior to imaging with TEM. TEM images
were recorded on a LaB 6 filament JEOL1200 TEM
operating at an accelerating voltage of 80 keV at a
50,000X magnification. Images were recorded by a
Gatan wide-angle CCD camera.
Cellular TEM processing was carried out using
standard TEM processes of fixation, dehydration,
infiltration, trimming and sectioning as detailed pre-
viously (Guggenheim et al. 2016). Cellular TEM
imaging was carried out on an FEI Tecnai G2 Spirit
operating at 80 keV (FEI, Center for Advanced
Microscopy, Northwestern University, Chicago, IL).
Images were taken with a Gatan imaging camera.
200 mesh Formvar coated copper TEM grids were
loaded into the TEM and cells of interest, that were
previously imaged during RCM and R-SIM experi-
ments, were located on low (690X) magnification,
and then imaged at higher magnification (up to
49,000X) to visualize individual and clusters of NPs.
TEM processing was performed as previously
described for correlative experiments (Guggenheim
et al. 2016).
Microscopy: confocal and SIM
Cells immersed in VS or PBS were imaged using a
Nikon A1R inverted confocal microscope (Nikon
Corp, Japan). Images were acquired using Nikon
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A1R (BALM, UK or NIC, Chicago). To set up the
reflectance optical configuration in NIS Elements,
the first dichroic mirror was set to B520/80 to facili-
tate light transmission and reflectance, the fourth
channel was set up for reflectance imaging using
the 488 nm laser, and all channel light paths were
set to through. The CTO stain was excited using the
561 nm laser, DAPI nuclear stain was excited using
the 405 nm laser. Red fluorescent protein (RFP) and
lysosomal stain were also excited using the 561 nm
laser. The same samples were imaged using reflect-
ance Structured Illumination Microscopy (R-SIM)
(Nikon Corp., Japan) with an EM-CCD camera iXon3
DU-897E (Andor Technology Ltd.). To facilitate
reflectance SIM image acquisition, a half mirror
(50% transmitted/50% reflected) filter cube was
placed into the light path. The 488 nm or 405 nm
laser was used to illuminate the sample using 2D-
SIM imaging. The 561 nm laser was used to excite
cytoplasmic CTO stain in wide-field mode. The
561 nm laser was also used to excite RFP and lyso-
somal stain in 3D-SIM acquisitions.
Image processing and analysis
Image processing and analysis were conducted with
FIJI (ImageJ) or MATLAB 2011 b/2016a/2017b. For
TEM imaging: image filtering was performed (filter
size 4; sigma 2), and objects were detected using
thresholding. The boundaries of the regions
detected in the original image, Supplementary
Figure S1(B), are shown in red in Supplementary
Figure S1(C). Once the objects were detected, the
area of each object was measured as a pixel area,
which was converted into a diameter (in nm) using
pr2 and the known pixel size using the assumption
of a sphere. For all cell experiments, cells were seg-
mented manually or automatically using FIJI and
MATLAB. Results were calculated as an average
over the specified number of cells. For NP uptake
experiments, NP regions were also segmented
(MATLAB) and where fluorescent markers were used
these too were segmented automatically. The auto-
mated procedure is indicated in Supplementary
Figure S4). Briefly, it comprises the use of image fil-
tering, background subtraction, and signal detection
(NP (reflectance), cell outline (fluorescent 561 nm)
and nuclear outline (fluorescent 405 nm)) through
K-means unsupervised clustering. This is followed
by an iterative process that assesses properties of
cells on an individual basis using ‘for’ loops, collates
the data and displays it graphically (Supplementary
Figure S4).
Statistical analysis
Statistical analysis was performed using students
t-test where two comparisons were being made or
determined by ANOVA and subsequent multiple
comparisons (Tukey-Kramer) in MATLAB when
more than two sets of results were being com-
pared. In each case the significance levels were:
p< 0.001; p< 0.01; p< 0.05.
Results
Nanoparticle characterization: TEM
TEM was performed to examine the Siennaþ SPION
stock solution. TEM is the gold standard for NP
imaging due to the ultrahigh-resolution offered and
the ability to visualize individual NPs. The mean of
the 902 detected regions or NP cores was 4.5 nm ±
2.7; the median value was 4.1 nm. This agrees with
the manufacturer’s specifications of a 4.2 nm core.
As seen in Supplementary Figure S1(A), the SPION
size distribution is relatively narrow, with the peak
between 4 and 5 nm. However, SPIONs appear as
larger structures (possible agglomerates) in some
areas (Supplementary Figure S1(A,B)). This was evi-
denced in the distribution plot in Supplementary
Figure S1(A), where a small percentage of NPs are
observed with a diameter >10 nm. The maximum
diameter observed is 25.99 nm.
NP characterization: DLS and zeta potential
NP properties, including Zeta potential, size, and
size distribution (as indicated by the polydispersity
index, PDI) by DLS were measured in the different
media, including Phosphate Buffered Saline (PBS),
Table 1. Summary of the main physiological properties of
SPIONs in the different media used for experiments including
control measurements in PBS, SCM (DMEM and RPMI) and the
artificial lysosomal fluid (ALF).
Solution Hydrodyanmic size Zeta PDI pH
PBS 58.8 ± 3.9 11 ± 4.4 0.204 ± 0.04 7.4 ± 0.04
DMEM-SCM 65.05 ± 5.0 8 ± 0.77 0.222 ± 0.004 8.4 ± 0.035
RPMI-SCM 65.7 ± 3.6 8 ± 0.59 0.236 ± 0.03 8.3 ± 0.12
ALF 80.2 ± 4.2 11 ± 4.7 0.263 ± 0.03 4.1 ± 0.015
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Dulbecco’s Modified Eagles Medium (DMEM) Serum
Containing Media (SCM), Roswell Park Memorial
Institute (RPMI) SCM and Artificial Lysosomal Fluid
(ALF) (Table 1). The p-value for the 1-way ANOVA
performed on the data for size, zeta, PDI and pH
respectively are (0.0012, 0.0046, 0.1699 and
1.7x1012). Post-Hoc testing (Tukey-Kramer) in
MATLAB indicated that the size of the SPIONs meas-
ured by DLS is statistically significantly different
between ALF and the other three conditions. The
same method of post hoc testing also indicated
that the measured zeta potential of the PBS sample
was significantly different from the zeta potential of
the other three media tested. No significant differ-
ence was seen between observed PDIs.
According to the manufacturer, the nominal aver-
age hydrodynamic diameter of Siennaþ SPIONs is
60 nm (4 nm core plus coating); this appears to
agree with our results obtained in PBS solution
where a z-average diameter of 58 ± 3.9 nm and
peak-1 intensity of 70.16 nm±0.25 nm was
observed. DLS data for the suspension DMEM-SCM
control without NP presence gave rise to two peaks
at 10 nm and 70 nm of similar magnitude, corre-
sponding to protein and lipid aggregates from the
serum (Supplementary Figure S2(A)). Upon NP
immersion into biological media, DMEM-SCM and
RPMI-SCM (Table 1 and Supplementary Figure S2),
the hydrodynamic size of the NPs increased com-
pared to the NP-PBS sample up to 65.05 nm and
65.7 respectively; this likely indicates a combination
of agglomeration and protein adsorption to the sur-
face of the NPs. There was also a decrease in the
observed 10 nm peak intensity with increasing con-
centration of NPs compared to the SCM control,
indicating a decrease in the contribution of free
protein in the media due to NP-protein binding
(Supplementary Figure S2(B)). The PDI of the NP
preparation also increased following the addition of
DMEM/RPMI-SCM (Table 1). This may be expected,
as protein adsorption to the NP surface can lead to
changes in the hydrodynamic size as well as induc-
ing bridging between NPs. The properties of the
SPIONs were also measured in the ALF solution to
indicate their properties inside the acidic lysosome
environment.
Properties of NP suspensions can also change
over time; when dispersed in an aqueous media
NPs tend to interact with their surroundings. This
can lead to agglomeration into larger loosely bound
structures or strongly bound aggregates. Therefore,
the physicochemical properties were measured over
a 2-hour time course (the duration of the uptake
and localization experiments), in DMEM/RPMI-SCM.
No significant change in size, size distribution or
charge, and in solution pH were observed through-
out the 2-hour experimental time course
(Supplementary Figure S2). Given that the Siennaþ
SPIONs are coated in carboxydextran, it is likely that
steric effects are the main initial stabilizing forces
within these NP suspensions, as is also the case for
dextran-coated SPIONs in suspension (Sonvico
et al. 2005).
Toxicity of SPIONs measured by SYTOX
staining intensity
Siennaþ toxicity was assessed in MDA, HeLa, and
A549 cancer cells, along with THP-1 derived macro-
phages via assessment of membrane permeabil-
ization. THP-1 monocytes were differentiated into
macrophages using a published protocol
(Daigneault et al. 2010). Differentiation was con-
firmed using microscopy, known morphology of
THP-1 derived macrophages and FACS to assess
side scatter, forward scatter, and CDC36 expression
(Supplementary Figure S3). Cancer cells and THP-1
derived macrophages were exposed to SPIONs at a
concentration of 280 mg/mL. SYTOX green was
applied to the cells 24 hrs post SPION incubation
and cells were fixed and mounted in VS containing
DAPI. A positive control for membrane damage
(saponin) was included. Saponins selectively interact
with membrane cholesterol, removing it and form-
ing membrane pores allowing SYTOX uptake into
the cell where it binds DNA leading to fluorescence
(Lacaille-Dubois and Wagner 1996).
The characteristic SYTOX staining of nuclei can
be seen in cells treated with saponin, however, this
was not evident in SPION treated cells or negative
controls. NP treatment at 280mg/mL, therefore,
does not appear to have caused cellular damage or
death, as measured by membrane permeabilization
(Figure 1). Previous evidence suggests that some
NPs can bind to, or react with, some toxicity assay
components causing interference and limiting the
interpretation of the particular assay without appro-
priate controls (Ong et al. 2014). To rule out the
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Figure 1. SYTOX green assay for membrane permeabilization. (A) HeLa cells exposed to Saponin, SaponinþNP, NP alone and
control. The top panel shows cytoplasmic stain, 24 h following NP incubation with 280mg/mL SPIONs. Bottom panel shows SYTOX
green fluorescence that is evident in both samples treated with saponin, and not in the negative control or NP treated samples.
(B) Graphical representation of the quantification of nuclear SYTOX intensity, analyzed automatically using MATLAB. Significant dif-
ferences were seen between saponin treated samples and non-saponin treated samples only. Students t-Test gave significance of
p< 0.001 between saponin treated and non-saponin treated samples in each cell line.
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possibility of NPs binding to SYTOX dye, thus pre-
venting fluorescence in the presence of membrane
damage, a saponinþ SPION treated control was
included. Figure 1 shows example confocal images
from HeLa cells depicting the SYTOX green staining
and cell cytoplasm stain. It is clear that no SYTOX
intensity is visualized in the negative control or
SPION treated samples. These same trends were
seen in all other cell lines tested (MDA, A549 and
THP-1 derived macrophages). No statistically signifi-
cant difference was seen between the negative con-
trol cells and the Siennaþ treated cells in any cell
line tested. Additionally, no significant difference
was seen between saponin treated cells and the
NP-saponin treated cells. There was however a sig-
nificant difference between the NP treated group/
negative control and the cells that included saponin
in the treatment (Figure 1). The addition of the NP-
saponin indicated that NPs caused an apparent
small reduction in the amount of nuclear staining
compared to the saponin alone positive control,
however this was not statistically significant.
Uptake of SPIONs into different cancer cell lines:
A549, MDA, HeLa, and THP-1 derived
macrophages
The uptake of SPIONs was assessed in four different
cell types including A549, HeLa, MDA and THP-1
derived macrophages at a variety of exposure times
(1 hr, 15 mins and 5 mins) and concentrations
(280 mg/mL, 112 mg/mL and 56 mg/mL). It is apparent
from Figure 2(A), in the treated images compared
to the controls, that SPIONs are efficiently internal-
ized into all cell lines tested under these exposure
conditions, indicating that all cell lines are capable
of internalizing SPIONs. Although uptake is clearly
seen, when comparing treated (Figure 2(A): top
panel) and control cells (Figure 2(A): bottom panel),
it is very difficult to ascertain differences between
the cell lines themselves based on judgment alone.
The uptake of SPIONs into these different types of
cells can be quantified using verified automated
processing and analysis workflows (Supplementary
Figure S4). Although any number of different
parameters can be measured during this process,
intensity measurements across single cells and
number of detected regions are the primary indica-
tions for NP uptake assessed here.
Supplementary Figure S5 compares the mean
cellular intensity for the exposed cells for each cell
line tested, grouped by concentration and time
points. Increased SPION exposure time and expos-
ure concentration lead to increased cellular inten-
sity in all cell lines tested (Supplementary Figure S5)
as expected, with no indication of saturation. In
some cases, significant differences between differ-
ent time points treated with the same concentra-
tion were observed (THP-1, MDA, and A549). This
may indicate a stronger dependence on time for
uptake. MDA cells show significantly different
uptake amounts at nearly all concentrations and
time points tested, which may indicate an increased
sensitivity to NP uptake, through an increased
amount of receptor availability at the surface of
these cell types, or as a result of MDA cells utilizing
multiple pathways or experiencing a certain level of
membrane damage, leading to increased NP intern-
alization, particularly at the earlier time points. Due
to the small differences seen between uptake
amounts at lower concentrations and time points
(Supplementary Figure S5), the results obtained for
each cell line at the highest tested concentration
and longest exposure time points were compared
(Figure 2(B3,B6)). THP-1 macrophages internalize
more NPs when compared to the cancer cell mod-
els, however when uptake is compared at the short-
est time point the difference was not significant.
Macrophages possess specialized internalization
capabilities, termed phagocytosis which differs from
conventional endocytosis, and involves formation of
large intracellular phagosomes (>5mm in size),
resulting in the engulfment of large amounts of for-
eign material (Aderem and Underhill 1999). Based
on the results seen here, it may be inferred that the
route of uptake within macrophages could differ to
that of other cell types, which has previously been
suggested (Wahajuddin and Arora 2012). Again,
time seems to have a more significant effect than
concentration on THP-1 uptake of NPs (based on
the 56 lg/mL and 5 mins results) (Figure 2(B3,B6)).
When comparing MDA, HeLa and A549 cells, similar
levels of uptake are observed, and no statistical dif-
ference between groups is seen, as measured by an
ANOVA and multiple comparisons (Tukey-Kramer) in
MATLAB. This may imply a similar route of uptake
in these cell lines that may differ to that of
macrophages.
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To consider the possibility of differences in
uptake amount between the cell lines at the lower
concentrations and time points, results were also
plotted for the mid and low concentrations and the
15- and 5-minute time points. When looking at the
data, there are very few statistically significant dif-
ferences between the cancer cell lines themselves,
not including the THP-1 cell line, as seen from the
graphs in Figure 2(B), and as measured by an
ANOVA and multiple comparisons (Tukey-Kramer) in
MATLAB. A significant difference between MDA and
A549 cells was found in only three cases: in the
mid concentration experiment with one-hour time
point (Figure 2(B2)), and then again in the
15minutes incubation group, at the mid and high
concentrations (Figure 2(B5)). Interestingly, there
is no significant difference between A549 and HeLa
cells at any concentration or time point, indicating
Figure 2. Uptake of SPIONs into cancer cells and THP-1 derived macrophages. (A) RCM images show SPION internalization into
different cell lines. Uptake is evident in all cell lines. NPs highlighted with arrows. (B) The graphs show comparisons of the aver-
age (mean) intensity of cells following a treatment with 280mg/mL SPIONs for different time points (left) and incubated for 1 h at
different concentrations (right). Statistical significance was calculated using MATLAB ANOVA, ‘anova1’, and ‘multcompare’ func-
tions. Multcompare uses Tukey-Kramer post hoc testing by default. THP-1 cells appeared to internalize NPs significantly more than
the cancer cells p< 0.001.
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that there is a similar level of uptake in these cell
types, highlighting a consistent mechanism of
uptake and sensitivity to the particles. However, the
MDA cells show significantly different uptake pat-
terns to A549 cells and HeLa cells when looking at
the 15minutes incubation group and the high and
mid concentrations. This could indicate that the
MDA cells are internalizing NPs more quickly than
the A549 and HeLa cells, supporting data that indi-
cates the MDA cells might be more sensitive to
these particles.
Neighboring cells have been seen to undergo
different responses to NP treatments, and cell aver-
aging has been suggested to mask subtle changes
that occur in minority populations. To overcome
this, the distribution of cell intensities was binned
to highlight distinct differences in the uptake across
times and concentrations (Supplementary Figure
S5(C)). For each cell line, in each group there is evi-
dence of a portion of cells that do not internalize
any NPs (indicated by the visible bars at the far left
of the figure at 0); however, as time and concentra-
tion increase there is a clear increase in cellular
intensity and therefore internalization across all cell
lines. Although increases in time and concentration
both lead to an increase in the observed NP uptake
intensity, analyses again indicate that time is a
more significant contributor than concentration
(Supplementary Figure S5(A,C)). MDA cells appear
to show what looks like a more spread out distribu-
tion of uptake based on the binned data analysis,
as a lot of treatment groups have cells that exhibit
high intensities (to the right side of the histogram),
compared to the A549 and HeLa cells, where mainly
the high concentration and long exposure time
groups exhibit high intensities.
Supplementary Figure S5(C) shows that the cells
that experience the longest duration of incubation
generally show largest proportions of higher inten-
sity cells when compared to the incubations for
shorter times at the higher concentrations. This
could be confirming the importance of exposure
time. This could potentially indicate a receptor-
density limited nature of the uptake occurring.
Likewise, exposure time is known to have an effect
due to the increased sedimentation of particles
over time, potentially leading to a higher effective
dose of NPs at the cell surface. Dosimetry of NP cul-
tures is becoming increasingly important to model
and understand to enable determination of the
dose received by different cell lines, and how these
change over time. Although this is beyond the
scope of the current article, a detailed analysis
modeling the transport of NMs to the cell surface
considering cell-specific receptor densities and
types, would be very interesting for future work
(DeLoid et al. 2015 and Hinderlinter et al. 2010).
The cells that experience higher NP exposure
concentrations appear to have more cells internalize
some NPs (i.e. broad peaks but at a lower intensity)
and fewer cells with no NPs. This could indicate
that although at higher concentrations a larger pro-
portion of the total cells take up some NPs, at lon-
ger time points a greater proportion of the NPs are
taken up, potentially due to receptor recycling and
continued uptake, in addition to increased sedimen-
tation of NPs through longer exposure periods
(Supplementary Figure S5(C)).
Mechanism of uptake: membrane-bound or
fluid phase?
The NPs are known to interact with molecules at
the cell surface, and can subsequently be internal-
ized specifically through membrane interactions, via
receptor-ligand mediated active processes or elec-
trostatic interactions, or through nonspecific routes
such as passive fluid encapsulation within vesicles
during internalization processes. A series of calcula-
tions were performed to determine the potential
for uptake through direct membrane interaction
versus uptake due to passive incorporation into
vesicles in the liquid phase (Smith et al. 2012).
The equations, shown in Figure 3, can be used to
quantitatively estimate the likelihood of NPs enter-
ing cells through each mechanism based upon the
properties of the vesicles and the NPs themselves
(e.g. size) (Figure 3). The number of NPs/mL of
medium can be calculated and substituted into the
equations in Figure 3, to calculate the likelihood of
fluid-phase and membrane interaction occurring. In
each case, the calculation for NP attachment at the
surface is likely to be an over-estimation, partly due
to neglecting the membrane surface curvature. The
calculations are also based on the assumption that
the entire membrane surface has the capacity to be
coated in NPs. Despite this, the analyses indicate
that NPs are likely to bind specifically to
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membranes or membrane proteins/receptors at the
cell surface and be carried into the cell through dir-
ect attachment, rather than being taken up within
the vesicular fluid, as evidenced in Figure 3.
However, as the vesicle size itself increases (such as
phagosomes >5 mm) the chances of encapsulation
increases 10-fold, as seen in Figure 3.
Mechanism of SPION uptake into different cancer
cell lines: A549, MDA, HeLa, and THP-1 derived
macrophages
SiRNA targeted to proteins in common internaliza-
tion pathways within cells were utilized to elucidate
the main uptake pathway of SPIONs. SiRNA targeted
toward AP2 was employed to inhibit the CME path-
way, with Cav1 targeted to inhibit caveolae medi-
ated endocytosis, and Pak1 to inhibit
macropinocytosis. To determine the route of NP
uptake, experiments were performed with control
cargo known to enter cells through the specific
routes (transferrin, cholera toxin and dextran) to
determine that the knockdown system was working
(Supplementary Figure S6(D)). Western blotting was
performed alongside each experiment to ensure
knockdown had occurred (Supplementary Figure
S6(D)). Following siRNA inhibition, cells were treated
with SPIONs and their uptake assessed relative to a
non-silenced positive control (100%). Protein
expression and knockdown levels were quantified
from western blot experiments, normalized to the
housekeeping gene tubulin (Tub) and expressed as
a percentage of the non-silencing control (NSC)
(Figure 4). The mean inhibition of each pathway
was >70% in each cell line and with each siRNA as
determined from the expression levels of the
knocked-down proteins. Cav1 expression in macro-
phages has been debated, and some macrophages,
Figure 3. Calculations to obtain the number of particles that can enter a cell through fluid-phase endocytosis compared to recep-
tor mediated endocytosis. Figures and equations adapted from Smith et al. (2012). (A) The equations can be substituted to deter-
mine the most likely means of NP cellular entry: fluid phase, or receptor mediated. The close circle packing density (where all NPs
are touching and attached at the surface) is 0.91. The curvature of the membrane is neglected and therefore this will be a slight
over estimation. This likelihood is determined computationally using MATLAB for every vesicle diameter between 150 nm and
5000nm in increments of 1 nm (displayed graphically as ‘likelihood’). (B) The calculation of likelihood is given for 3 examples with
and without clathrin coat, each of these gives an example of how ratio of likelihood of internalization through RME compares to
that within the fluid phase (based on the extracellular starting concentrations).
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notably those derived from human monocytes
(HMDMs), have been found to lack expression of
cav1 (Gargalovic and Dory 2001; Gaus et al. 2004;
Daigneault et al. 2010). Likewise, THP-1 derived
macrophage have been found to resemble HMDMs
when following the differentiation protocol
employed in this work (Daigneault et al. 2010). No
expression of Cav1 was detected in THP-1 derived
macrophages, as seen from the Western blot
(Supplementary Figure S6(D)). Therefore, no experi-
ments were performed to assess the effects of cav1
inhibition on THP-1 cells.
There are cell-type dependant effects on SPION
internalization when AP2 is inhibited; the internal-
ization does not decrease significantly in MDA,
HeLa, and A549 cell lines (Supplementary Figure
S7). THP-1 cells, however, appear to internalize NPs
under all siRNA inhibition conditions except for AP2
inhibition, indicating a difference in the internaliza-
tion mechanisms in these different types of cells.
These results indicate that CME is involved in the
internalization of Siennaþ SPIONs into THP-1
derived macrophages (Supplementary Figure S7).
Intracellular SPION intensity dropped to 40% of that
in NSC cells following AP2 inhibition (Figure 4) and
is similar to the expression loss of AP2. By contrast,
the inhibition of Pak1 protein expression was nearly
90% however the internalization of NPs remained
roughly the same as in the NSC cells. A well-known
cargo for the CME route is the transferrin receptor
(TfR), along with its ligand, transferrin (Tf). Tf is
known to bind to many different NPs and thus may
offer a mechanism of entry for corona coated
SPIONs in these cell types (Raynal et al. 2004; Arbab
et al. 2005). Corona studies performed on the
SPIONs used here identified the presence of Tf, indi-
cating this as a potential mechanism of entry into
the THP-1 cells through the CME pathway
(Supplementary Figure S8); likewise the presence of
Tf bound to CeO2 NPs has been shown to be
involved in receptor mediated endocytosis via CME
(Mazzolini et al. 2015).
The quantitative analysis of non-macrophage
cells suggests the importance of caveolin mediated
endocytosis in Siennaþ NP internalization (Figure 4).
In HeLa and MDA cells the inhibition of caveolin led
to a significant decrease in the internalization of
SPIONs (p< 0.05). In A549 cells there was a similar
decrease, however, this was not significant
(p¼ 0.08). There are limited identified cargo for cav-
eolin mediated endocytosis, but other NPs/QDs of
similar size (60 nm) have been found to preferen-
tially accumulate in cells via caveolin mediated
endocytosis (Zhang and Monteiro-Riviere 2009;
Bohmer and Jordan 2015). Albumin was found to
be present on the surface of the SPIONs used here
Figure 4. Quantification of SPION uptake following siRNA experiments in cancer cell lines by average cell intensity. Quantification
of the NP uptake (using MATLAB to determine average cellular intensity) indicating the inhibition of NP uptake when specific
pathways are inhibited in different cell lines. The graph on the right shows quantification of average knockdown efficiency from
Western blots. A minimum of 238 cells were analyzed per group, from experiments run on 3 or more different days. Meanþ SEM
is plotted).
NANOTOXICOLOGY 15
(Supplementary Figure S8), consistent with studies
of the corona composition of dextran coated
SPIONs with neutral, or nearly neutral charge
(Sakulkhu et al. 2015). Albumin binds to gp60 at
the cell surface, which binds to Cav1 and forms
vesicles, potentially providing a mechanism for
internalization of SPIONs, although this is specula-
tive (Miele et al. 2009).
The inhibition of macropinocytosis using siRNA
directed toward Pak1, a kinase directly involved in
macropinocytosis, led to a significant decrease in
SPION internalization in HeLa and A549 cells.
Interestingly the inhibition of Pak1 in MDA cells did
not lead to a decrease in the detected reflectance
intensity. However, following Pak1 siRNA treatment,
MDA cells consistently appeared to exhibit vacuole
formation, evident in the reflectance images
(Supplementary Figure S7), such that the contribu-
tion of SPIONs to the reflectance signal could not
be deduced. More experiments are necessary to
determine the effect of Pak1 inhibition on SPION
uptake in MDA cells and the reason for the forma-
tion of vacuoles.
The contribution of phagocytosis to SPION
uptake was also assessed in PMA-differentiated
THP-1 cells. Cytochalasin D was used to inhibit
phagocytosis, validated by measuring the uptake
of 1.1 mm fluorescent polystyrene beads
(Supplementary Figure S9). Measurements of the
mean intensity of cells indicated that when phago-
cytosis was inhibited in THP-1 macrophages, the
uptake of SPIONs decreased. However, when only
20-30% of phagocytosis functionality remained,
50%-70% of SPIONs still entered the cells
(Supplementary Figure S9), presumably, as SPIONs
were able to enter through other means such as
endocytosis, likely through a CME route as indicated
in earlier siRNA inhibition experiments (Figure 4).
Intracellular fate of SPIONs following uptake into
different cancer cell lines: A549, MDA, HeLa, and
THP-1 derived macrophages
Tagged proteins involved in endocytic trafficking
(Rab5, Rab7, and Rab11) were expressed in HeLa
cells to identify potential trafficking routes for
SPIONs. SPIONs appear to colocalize with various
compartments within the endosomal system over
the course of 48 hours (2,880minutes)
(Supplementary Figure S10). Image randomization
was also performed, and random object colocaliza-
tion between SPIONs and randomized fluorescence
images was measured, averaging at 7%. SPIONs
appear to colocalize with various compartments
within the endosomal system, particularly notice-
able around the 360minutes/6-hour point. A por-
tion of the SPIONs appears to colocalize to Rab5
positive compartments ranging from around 10%,
with this resembling random colocalization
measured at 7%, at 30minutes, up to 45% at
360minutes (or 6 hours) (Supplementary Figure
S10). Thereafter it begins to plateau at around 20-
30%. Colocalization between Rab11 and SPIONs is
also evident, starting around 10%, again resembling
the value for random colocalization. Increased
colocalization occurs by 360minutes (6 hours) indi-
cating that some of the SPIONs are destined to
return to the plasma membrane following internal-
ization, potentially highlighting transcytosis poten-
tial. Resovist has previously been reported to be
extruded from the cell, visualized extracellularly on
TEM images (Chung et al. 2015). If SPIONs are being
recycled to the surface this could explain, in part,
the continued level of association between Rab5
and SPIONs at 1440 min (24 hours) and 2880 min
(48 hours) due to release and re-uptake.
Colocalization of SPIONs with Rab7 positive com-
partments represents the accumulation of SPIONs
within the more acidic Rab7 late endosome com-
partments, which is a prerequisite for the matur-
ation and fusion with lysosomes, and subsequent
degradation of SPIONs. Colocalization between
SPIONs and Rab7 was observed here, ranging from
10-15% at 30 and 60 mins, increasing to 50% at
360 mins (6 hours) and remaining high until 1,440
mins (24 hours), before dropping back to around
30% at the later time points. Rab7 also marks lyso-
somal compartments. It is likely that during the
24 hour time course Rab7 compartments fuse with
lysosomal compartments and therefore may be
coupled to the beginning of SPION degradation in
the acidic lysosomal environment, which has been
reported to occur as early as 24 hours post incuba-
tion (Yang et al. 2011). Statistical testing was per-
formed using an ANOVA to compare the differences
between the different groups of data collected for
the Rab5, Rab7 and Rab11 colocalisation studies.
The resultant p-value of 7.5 x 108 indicated that
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significant differences were present within the data.
Post-Hoc testing, using the multcompare function
using the Tukey-Kramer method, indicated no statis-
tical significance between most groups tested.
There was however a significant difference between
the colocalization observed with Rab7 at 60 mins
compared to 360min (6 hours) and 1440min
(24 hours), and Rab 5 at 30min, and Rab5 at
360min (6 hours).
The colocalization of SPIONs with the lysosome
compartment was visualized using Lysotracker Red
DND-99 with the SPIONs visualized by reflectance
(Figure 5). Little colocalization was observed at the
earliest time points, however, colocalization
increased notably at 6 hrs, similar to the increase in
colocalization observed between SPIONs and Rab7
(Supplementary Figure S10). This is not surprising
as lysotracker can also mark late endosomes, due to
its pH sensitivity. Likewise, Rab7 has been deter-
mined necessary for fusion (in conjunction with
other proteins such as SNARES) of late endocytotic
structures and the lysosome; Rab7 can therefore
also act as a marker for lysosomal compartments
(Bucci et al. 2000; Vanlandingham and Ceresa 2009).
Lysosomal accumulation of SPIONs reaches a max-
imum of 81%, but the curve appears to plateau
(Figure 5), which could be indicative of lysosomal
saturation or the onset of particle dissolution and
degradation. These colocalization studies indicate
that the lysosome is the predominant destination
for SPIONs once internalized within macrophages.
This was also confirmed in MDA, A549 and THP-1
cells at the 24-hour time point following SPION
treatment (Figure 5(C)).
Super-resolution imaging of lysosomal
colocalization
Super-resolution microscopy can offer added bene-
fit when performing colocalization studies. Figure
6(A) shows the lysosomal colocalization of Siennaþ
imaged with RCM and R-SIM in conjunction with
fluorescent labelling of the lysosomes. The reso-
lution increase is clearly demonstrated in Figure
6(A) compared to Figure 6(B). This supports the
above findings that a large proportion of the NPs
do indeed colocalize with the lysosome following
cellular internalization in as little as one hour.
Techniques such as R-SIM have been shown to
reduce the colocalization uncertainty found in light
microscopy studies; however the disadvantages of
R-SIM include the high level of background signal
which leads to a decrease in NP detection when
compared to confocal (Guggenheim et al. 2016;
Guggenheim et al. 2017). Combination of techni-
ques in so called correlative methodologies can
provide increased certainty to the observations
made from confocal and SIM investigations, as
shown previously for SPIONs and cerium dioxide
NPs (Guggenheim et al. 2016). Figure 6(C) shows a
TEM micrograph of Siennaþ NPs following uptake
into HeLa cells that had previously been imaged
using light microscopy. The intracellular NPs from
the lower portion of the cell are evident (as indi-
cated by the white box on Figure 6(D) (although it
should be stated that this confocal image is itself a
Z-projection), as is the membrane that encapsulates
the NPs, confirming that the NPs are internalized
through the endo-lysosomal system.
Dissolution of NPs in lysosomal mimic fluid
Dissolution studies were performed in H2O at pH 7
or pH 4. The DLS, pH and Zeta potential were taken
at 24-hour intervals following initial incubation of
the SPIONs (Supplementary Figure S11). Some
changes were observed in the SPION preparations
(7000 ppm/7mg/mL) over the period of 144 hours
when incubated at pH4 and 37 C in H2O, however,
there was no indication that dissolution was occur-
ring and DLS indicated that size was increasing. The
carboxydextran coating is linked to the NP surface
via multiple hydrogen bonds. At low pH, the carb-
oxyl groups become protonated (Di Marco et al.
2007). The oxygen becomes electro-negatively
charged, and the hydrogen electro-positively
charged due to the electron withdrawing effect of
oxygen. Therefore, electrostatic interactions
between neighboring molecules could lead to
agglomeration of NPs under this condition, which
would explain the observed increase in diameter of
the NPs. This data indicates that low pH alone is
insufficient to induce the dissolution of the SPIONs,
which is in agreement with previous studies (Arbab
et al. 2005).
Dissolution measurements were also performed
in an artificial lysosomal fluid (ALF) (Stebounova,
Guio and Grassian 2011). It had been theorized that
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after 96 hours SPIONs would have dissolved com-
pletely within lysosomal fluid (Arbab et al. 2005).
The DLS, pH, Zeta potential and PDI were taken at
24-hour intervals following initial incubation (Figure
7). Correlating samples were also analyzed at each
time point to measure the reflectance intensity
using RCM (Figure 7(A)).
Reflectance intensity was measured through
automatic background subtraction and manual
delineation due to the high confluence of cells at
these longer time points. A decrease in reflectance
intensity was observed during the 96 hours in A459
cells (Figure 7(A)) but this may be due to NP distri-
bution to daughter cells during mitosis (Mazzolini
et al. 2015). During the dissolution study in ALF,
decreases in the observed diameter were observed
from T¼ 0 (78.1 ± 3.3 nm) to T¼ 96 (30.5 ± 4.4 nm)
indicating dissolution of the NPs in ALF (Figure
7(B)). The zeta potential also became more nega-
tive, from T¼ 0 (7.24mV± 0.39mV) to T¼ 96
(15.83mV ± 0.32mV) indicating an increase in
negative charge at the slipping plane of the NPs
(Figure 7(C)). The change in zeta potential is par-
ticularly evident at T¼ 24h which could indicate a
reduction in steric stabilization of the solution coin-
ciding with breakdown of the carboxydextran coat-
ing. There was also an evident increase in PDI from
T¼ 0 (0.18 ± 0.0036) to T¼ 96 (0.32 ± 0.1) which indi-
cates an increase in size distribution and is also
suggestive of the loss of the sterically stabilizing
Figure 5. Colocalization of SPIONs with the lysosome. A high degree of colocalization can be visualized at longer incubation time
points (24 hours and 48 hours especially). This can be seen from (A) the overlay (top left; SPIONs¼ gray, Lysosome¼ red) and the
line intensity profile (lysosome¼ blue, SPION¼ green). These images can be computationally post processed and different param-
eters assessed (such as the degree of signal overlap) and used to make quantitative conclusions about particle tracking and fate,
shown in (B). Plotted points show the mean result for each time point, error bars show the standard error of the mean (SEM).
Example images showing the colocalization between the lysosomes and the SPIONs at 24 hours, in the four cell lines tested are
displayed in (C).
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coating (Figure 7(E)). Taken together, the initial
studies to assess dissolution indicate that SPIONs
may be dissolving in the ALF solution. To confirm
these findings, SPIONs incubated in ALF were also
monitored for dissolved iron over the time course
of 144 hours (7 days) using ICP-OES. On each day,
starting 24 hours post initial measurement, samples
were prepared as described for elemental ICP-OES
analysis to separate the dissolved ions from the NP
fraction. A time dependant increase in the amount
of Fe ions present in solution was observed at each
concentration of SPIONs incubated in ALF (Figure
7(D)) (Motley et al. 2003; Stebounova, Guio, and
Grassian 2011). However full dissolution did not
Figure 6. R-SIM provides increased resolution for colocalization studies of metallic (e.g. SPION) NPs. When combined with TEM
this can indicate definitive localization. NPs with lysosomes in HeLa cells after an hour-long incubation. (A) Cells imaged with R-
SIM, (B) Confocal of SPIONs indicates colocalization with the lysosome, emphasizing the substantial resolution improvement of R-
SIM and confirming the findings that a large proportion of NPs colocalize to lysosomal compartments. TEM can also be included
in the workflow as described in detail in Guggenheim et al. (2017); an example of a TEM image showing the membrane-bound
structures containing SPIONs is indicated in (C) which corresponds to the cell shown in (D).
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appear to occur as the curve did not plateau as
would be expected at full dissolution. This supports
the conclusion that SPIONs are indeed partially dis-
solving in the low pH ALF solution. An important
consideration is the toxic effects of the intermedi-
ates formed during this dissolution process; not
only the resultant free Fe that is released. It is likely
that there is a complex interplay between the dis-
solution products and biological responses.
Discussion
Many of the traditional biomedical applications of
SPIONs rely on the selective cellular uptake of the
SPIONS by macrophage cells. However, over recent
years it has become more and more apparent that
NP uptake occurs across a wide range of cell types,
including non-phagocytotic cells. Cellular outcomes
following exposure to NPs are dependent upon a
variety of factors, including NP environment, NP pri-
mary particle properties, NP evolving properties and
the cell lines they encounter. Different cells have
evolved to carry out different functions, and as
such have varied cell surface properties which may
affect the uptake potential of NPs such as SPIONs.
The uptake kinetics of various SPIONs (DMSA-
coated, PEGylated, pullulan coated, Dextran coated)
have previously been studied in a variety of cell
lines (MCF-7, MDCK, NIH-3 T3, CHO-K1, Brain
Capillary Endothelial Cells (BCEC), human Blood
Outgrowth Endothelial Cells (hBOEC)), measured
through a host of techniques including magnetiza-
tion measurements, Prussian blue staining, AFM,
TEM and fluorescence imaging (Soenen et al. 2010;
Thomsen et al. 2013; Calero et al. 2015; Hanot et al.
2015; Silva et al. 2016). However, previous studies
did not made use of label-free imaging, instead uti-
lizing fluorescent imaging (Soenen et al. 2010;
Thomsen et al. 2013; Calero et al. 2015; Silva et al.
2016). NP labeling encompasses a host of potential
problems, including loss of label following uptake,
difficulty in label attachment, modification of NP
surface properties in addition to phototoxicity and
photobleaching effects in cells. Reflectance imaging,
as used here, provides an obvious alternative that
negates the need for labeling of NPs that are optic-
ally dense (Guggenheim et al. 2016).
Label-free RCM of SPIONs, applied in conjunction
with fluorescence labeling of cell structures allowed
the visualization and automated quantification of
intracellular Siennaþ SPION uptake under a variety
of conditions. Automation vastly increases the sam-
ple size that can be studied, in addition to increas-
ing result consistency and confidence. Initial studies
Figure 7. Dissolution of SPIONs in citrate containing ALF over a 96-hour time course. (A) A decrease in reflectance intensity is
seen over time with RCM. A decrease in the diameter (nm) (B) and zeta potential (C) is also observed, and this is paralleled by an
increased release of iron ions measured by ICP-OES (D) and an increase in the PDI (E) of the solution. Little change is observed in
the pH of the solution (F).
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indicated the efficient internalization of SPIONs
across all cell lines, at all time points and concentra-
tions tested. The time and concentration depend-
ence of uptake was established in multiple cancer
cell types, benchmarked against the widely studied
macrophage model, indicating distinct uptake
behavior and patterns. This is in accordance with
other results investigating the time and concentra-
tion dependence of uptake for a variety of NPs (e.g.
polystyrene and gold) and cell lines (Johnston et al.
2010; Trono et al. 2011; Smith et al. 2012; Mazzolini
et al. 2015).
Longer exposure times were found to exhibit a
greater effect on NP uptake compared to higher
concentrations for shorter exposure times. This
could be broadly related to the dosimetry and par-
ticle transport properties in the suspension media –
particles can sediment over time, which could lead
to higher effective doses at the cell surface.
Understanding the interactions between NMs and
the surrounding environment in terms of transport
is of emerging importance in this type of study,
and thus provides a new avenue for investigation in
future work to understand and model this process
(Guggenheim et al. 2018). Whilst we monitored the
NP suspension properties for the duration of the
study, and saw no significant change in the hydro-
dynamic size, we cannot rule out that particles
are sedimenting over time, leading to a higher
effective concentration at the cell surface at longer
exposure times.
The uptake patterns of HeLa, A549, MDA, and
THP-1 cells were compared to see if differences
were observed between different cell types. The
uptake of SPIONs into THP-1 cells was significantly
different from the uptake in any other cancer cell
under a variety of conditions, including all high
concentration experiments and all 1 hour exposure
times, indicating that the THP-1 cells do indeed
internalize a larger amount of SPIONs compared to
other cell types. There is little difference in the
uptake of SPIONs in A549 and HeLa cells, with no
significant difference seen between these cell lines
at any time point or concentration, indicating a
similar response to the dosage of SPIONs by these
cell types. Analyses of the uptake of SPIONs in MDA
cells across time and concentration groups indi-
cated a potential increase in sensitivity of the MDA
cells to SPIONS, as significant differences were seen
across different treatment groups of MDA cells
(Supplementary Figure 5 and Figure 2(C)). Likewise,
some differences were highlighted between the
uptake seen in MDA cells and the uptake seen in
A549 cells, however, these occurred only at the
mid-time points and concentrations, supporting ear-
lier data that indicates the MDA cells might be
more sensitive to these particles (Figures 2 and S5).
The increase in uptake over time could also be
indicative that a receptor-mediated interaction is
primarily responsible for the uptake of Siennaþ
SPIONs. This could indicate that uptake may be lim-
ited by the number and availability of receptors at
the cell surface and thus that receptors must be
freed before uptake can continue. To investigate
this idea, the likelihood of the NPs entering through
fluid-phase or through direct membrane interaction
was theoretically calculated. The results also sug-
gested, based on the uptake amount in THP-1 mac-
rophages compared to cancer cells, that different
mechanisms may be responsible for the uptake in
different cell lines.
The NPs can be efficiently internalized by a var-
iety of cell types through a combination of uptake
routes, including, but not limited to, clathrin-medi-
ated endocytosis (CME), caveolar endocytosis, mac-
ropinocytosis and, in specialized cells, phagocytosis
(Ivanov 2008; Sahay, Alakhova, and Kabanov 2010;
Gu et al. 2011; Zhao et al. 2011; Kafshgari, Harding,
and Voelcker 2015). In macrophage cells multiple
endocytotic mechanisms have previously been
found responsible for the internalization of SPIONs,
including CME, caveolae dependent mechanisms,
macropinocytosis and phagocytosis (Raynal et al.
2004; Xu et al. 2010; Gu et al. 2011; Lunov et al.
2011; Schlorf et al. 2010; Yang et al. 2011). The
internalization of SPIONs into macrophage models
has been widely studied compared to non-macro-
phage cell types. Fewer studies have focused on
non-phagocytosing cells, and those that do have
experimental flaws or artifacts. For example, SPIONs
were combined with uptake enhancing agents,
such as transfection medium or modified with pep-
tides (Daldrup-Link et al. 2003; Matuszewski et al.
2005). To investigate this further, the mechanism of
SPION uptake by each cell line was assessed.
In this work, several pathways were implicated in
the uptake of SPIONs. The uptake was determined
to be a result of internalization through membrane
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interactions and several key proteins were identified
that may be instrumental in facilitating the internal-
ization of these NPs, particularly Cav1 and Pak1 in
cancer cell lines. Conversely, in macrophage cells,
AP2 and the CME pathway appeared to play a
larger role in the internalization efficiency, along
with the classical mechanism of phagocytosis, spe-
cific to macrophage cell types. It is possible, or
even likely, that there is a complex interplay of
pathways and compensation occurring within the
cell types, particularly under siRNA inhibition condi-
tions. Considering the variety of surface coatings
and surface properties that are possible for different
NPs, and how the cellular surface constituents
modulate the NP surface and therefore nano-cell
interactions, it is likely that changing the identity of
surface adhered biomolecules (the biocorona) will
cause different mechanisms to play a role in the NP
internalization. Investigation into the NP associated
biocorona was also performed here to determine
potential key proteins that may be involved in the
uptake kinetics of the SPIONs into the cancer cell
lines tested here. Transferrin and albumin were
both detected as bound to the SPIONS
(Supplementary Figure S8), providing additional
support for the uptake routes proposed.
Many drug delivery strategies require NPs to
reach, or remain at, particular sites within the cell,
and therefore understanding of the trafficking and
biotransformation of NPs is important in ensuring
success and safety, in addition to ascertaining
potential for inadvertent toxicity. Various types of
SPIONs have been found to localize to endo-lyso-
somal compartments in vitro and previous studies,
in vitro and in vivo, indicate that the main fate of
SPIONs is degradation within the lysosome (Lunov
et al. 2010b; Levy et al. 2011). Most of these studies
have been performed in macrophage models using
fluorescently tagged NPs (Soenen et al. 2010a; Levy
et al. 2011). However, it is particularly important to
examine cellular interactions of the unmodified
Siennaþ SPIONs (i.e. without fluorescent tags) to
avoid modifying the surface chemistry and thus
potentially affecting the cellular outcome. In some
of the previous studies colocalization was deter-
mined using fluorescence, TEM and EDX, none of
which can provide absolute certainty of the localiza-
tion of unlabeled SPIONs to a particular compart-
ment such as the lysosome (Lunov et al. 2010b;
Levy et al. 2011). The data presented here
(Supplementary Figure S10) suggests that SPIONs
are trafficked through the endosomal transport sys-
tem to the lysosome, utilizing Rab5 and Rab7 posi-
tive compartments, with a fraction (increasing at
later timepoints) being released extracellularly
through Rab11 mediated recycling at each time
point upward of 6 hours. Evidence of SPION colocal-
ization with the lysosome also increased signifi-
cantly beyond 24 hours in all the cell types tested.
SPIONs were thus found to follow a classical path-
way that result in the lysosomal accumulation and
subsequent degradation into free iron. The relation-
ship between intracellular NP location and the
endo-lysosomal system/lysosomes was identified
using colocalization studies with the labeled lyso-
somal compartment.
One of the drawbacks of conventional diffrac-
tion-limited microscopy, such as confocal, is the
resolution limit (Verdat 1869; Abbe 1873; Rayleigh
1903). Therefore, two detected signals that appear
to co-localize may actually be, theoretically, up to
200–250 nm apart, and practically even further (Cox
and Sheppard 2004). Reflectance SIM (R-SIM) offers
a substantial resolution increase compared to con-
focal microscopy with no additional sample prepar-
ation (Chang et al. 2011; Guggenheim et al. 2016;
Guggenheim et al. 2017). This can improve the like-
lihood of observing true colocalization between
two detected signals. The use of R-SIM increased
confidence in the conclusions that the NP are local-
izing to within lysosomes following intracellular traf-
ficking; the further inclusion of TEM imaging
indicated that intracellular NPs were localized within
membrane bound structures. Taken together, this
indicates that SPIONs are taken up in a receptor
mediated fashion through cell surface interactions,
internalized and transported through the endolyso-
somal system with the ultimate fate of lysosomal
degradation in all cell lines tested. This localization
could be advantageous for therapeutic strategies,
such as those that employ a pH modulated cleav-
age of drug bound cargo within the endo-lysosomal
system (Zhang et al. 2013).
Once trafficked into the lysosome, the presence of
chelates with a high affinity for Fe3þ and an acidic
environment could cause SPIONs to dissolve in as lit-
tle as 96 hours (Arbab et al. 2005), although complete
dissolution of the SIENNAþ SPIONs was not observed
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over this timescale in the ALF dissolution studies pre-
sented here. Dissolution would lead to the release of
iron ions within the lysosome and cytoplasm; the
deleterious effects of free iron release and overload
are well known (Arbab et al. 2005; Yang et al. 2015).
Indeed Arbab et al. saw evidence for dissolution of
PLL-SPIONs over 96 hours, but they also observed
some undissolved SPIONs within membrane bound
organelles of treated cells (Arbab et al. 2005).
Dextran functionalization is one of the most favored
routes for stabilization of SPIONs, and the Siennaþ
SPIONs are coated in carboxydextran, however it is
suggested that the dextran coat is not firmly
attached at the SPIONs surface, therefore they may
not remain stable within the acidic lysosome. The
iron core and it’s coatings are thought to be
degraded by the acidic environment leading to the
release of free iron into the cytoplasm (Lunov et al.
2010a). Interestingly, the data for
SIENNAþpresented here shows that pH alone was
not sufficient to induce dissolution, but that in the
citrate containing ALF fluid, which mimics lysosomal
fluid, the SPIONs did undergo partial dissolution.
Together, the results of this study indicate that
SPIONs are efficiently internalized into all cell lines
tested, regardless of whether they are cancer cells or
macrophages. This contradicts the idea that SPIONs
are selectively taken up by macrophages, and not by
cancer cells, which forms the basis of some thera-
peutic uses of these SPIONs, particularly for MRI
imaging. It is clear that macrophages internalize sig-
nificantly more SPIONs then cancer cells, and this
enhanced uptake is likely to occur through different
mechanisms, highlighting a potential difference that
could be targeting for therapeutic intervention
where NP uptake is desired in specific cell popula-
tions. This also offers promise for the use of SPIONs
as drug delivery vehicles. This, combined with their
ability to be magnetically targeted to specific loca-
tions in the body could offer a very attractive cancer
therapy strategy. However, it is worth noting that the
studies performed here are carried out on 2D cell
cultures. Future studies should make use of new cell
culture methods that can recreate 3D cellular envi-
ronments, to identify the translocation and penetra-
tion of SPIONs into 3D cellular structures. Modeling
of this process could also be performed to under-
stand how this might impact SPION uptake in solid
tumors of different sizes.
Conclusions
Metal oxide NPs, such as SPIONs, have applications
from the inexpensive in vivo detection and screen-
ing of diseases such as cancer to the remediation of
polluted soils (Sokolov et al. 2004; Santra et al.
2009; Shipley, Engates, and Guettner 2011; Li et al.
2013; Wang and Cuschieri 2013; Dave and Chopda
2014). Some magnetite NPs have been identified in
the human brain as a result of particulate pollution
resulting from combustion (Maher et al. 2016). As
with all NPs, SPIONs encompass a huge range of
preparation types, each with different properties
that can lead to a variety of effects within cellular
systems and exposed organisms. Therefore, the
characterization of formulation physical chemical
properties, uptake into target and non-target cells,
localization and trafficking are of utmost import-
ance to try and prevent unwanted toxicities in add-
ition to successful application. Here, methods based
around the detection of unlabeled NPs, exploiting
the inherent reflectance from SPIONs, provide infor-
mation regarding the unlabelled particle uptake
into a variety of cell lines.
SPIONs are efficiently internalized into A549,
MDA, HeLa and THP-1 derived macrophages
through receptor mediated endocytosis, trafficked
through the endo-lysosomal system to the degrada-
tive lysosome. Here, it appears SPIONs begin to
degrade in the acidic lysosomal environment. It is
critical to understand more regarding the uptake,
localization, trafficking and fate of SPIONs in order
to safely apply them within biomedicine and allow
them to reach their full potential as therapeutic or
diagnostic agents without unwanted or unexpected
consequences. The present work makes important
strides in this direction, indicating that while the
behavior in non-phagocytotic cell lines is broadly
similar to that in the specialist macrophage cells,
some differences in the mechanisms of internaliza-
tion exist, that could potentially be exploited to
reduce off-target effects.
RCM offers tremendous benefit for NP investiga-
tions as it is quick, inexpensive and label-free,
resulting in high-quality images that can be subse-
quently analyzed computationally as demonstrated
in this work and previously (Mazzolini et al. 2015;
Guggenheim et al. 2016, 2017). Combining this
work with automated analysis methods provides a
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powerful workflow for obtaining quantitative infor-
mation regarding NP uptake and localization in a
non-biased manner. Continuation of this type of
investigation will ultimately lead to more accurate
predictions regarding the behavior of NPs within
cells and tissues, with the goal of improving the
likelihood of success in subsequent translation to
clinical trials. Despite increasing research into NP
based therapies, few of these realize their full
potential within a clinical setting (Alexis et al. 2010;
Duncan and Gaspar 2011; Venditto and Szoka
2013). RCM may be influential in reducing the num-
ber of formulations that are progressed to in vivo
studies with limited chance of success in future clin-
ical trials. Refinement of the experimental proce-
dures utilized in 2D cell cultures, such as siRNA
inhibition or localization studies, to allow the appli-
cation in 3D culture models, could also prove indis-
pensable in the future.
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